Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Waypharm is a German specialty pharmaceutical company focused on the development, registration, and distribution of niche and orphan medicinal products. Headquartered in Brühl, the company specializes in therapeutic areas such as the central nervous system (CNS) and oncology, providing essential therapies for patients with rare conditions. As a subsidiary of the Waymade Group, Waypharm leverages an extensive international network to facilitate market access and regulatory compliance across Europe. The company's portfolio includes both proprietary branded generics and distributed third-party pharmaceuticals. Waypharm is recognized for its expertise in navigating complex regulatory environments to bring specialized treatments to the German market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Waypharm.